FDA Adds Boxed Warning to Liver Disease Medication for Correct Dosing
February 2nd 2018Officials with the FDA have added a boxed warning label to liver disease medicine obeticholic acid (Ocaliva, Intercept) to highlight the correct dosing for patients with rare chronic liver disease, according to a FDA safety announcement.
Read More